...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
【24h】

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression

机译:对乙酰氨基酚和其他止痛/解热药抑制的环氧合酶1变体COX-3的克隆,结构和表达

获取原文
获取原文并翻译 | 示例
           

摘要

Two cyclooxygenase isozymes, COX-1 and -2, are known to catalyze the rate-limiting step of prostaglandin synthesis and are the targets of nonsteroidal antiinflammatory drugs. Here we describe a third distinct COX isozyme, COX-3, as well as two smaller COX-1-derived proteins (partial COX-1 or PCOX-1 proteins). COX-3 and one of the PCOX-1 proteins (PCOX-1 a) are made from the COX-1 gene but retain intron 1 in their mRNAs. PCOX-1 proteins additionally contain an in-frame deletion of exons 5-8 of the COX-1 mRNA. COX-3 and PCOX mRNAs are expressed in canine cerebral cortex and in lesser amounts in other tissues analyzed. In human, COX-3 mRNA is expressed as an ≈5.2-kb transcript and is most abundant in cerebral cortex and heart. Intron 1 is conserved in length and in sequence in mammalian COX-1 genes. This intron contains an ORF that introduces an insertion of 30-34 aa, depending on the mammalian species, into the hydrophobic signal peptide that directs COX-1 into the lumen of the endoplasmic reticulum and nuclear envelope. COX-3 and PCOX-1 a are expressed efficiently in insect cells as membrane-bound proteins. The signal peptide is not cleaved from either protein and both proteins are glycosylated. COX-3, but not PCOX-1 a, possesses glycosylation-dependent cyclooxygenase activity. Comparison of canine COX-3 activity with murine COX-1 and -2 demonstrates that this enzyme is selectively inhibited by analgesic/antipyretic drugs such as acetaminophen, phenacetin, antipyrine, and dipyrone, and is potently inhibited by some nonsteroidal antiinflammatory drugs. Thus, inhibition of COX-3 could represent a primary central mechanism by which these drugs decrease pain and possibly fever.
机译:已知两种环氧合酶同工酶COX-1和-2可催化前列腺素合成的限速步骤,并且是非甾体类抗炎药的目标。在这里,我们描述了第三个不同的COX同工酶COX-3,以及两个较小的COX-1衍生蛋白(部分COX-1或PCOX-1蛋白)。 COX-3和一种PCOX-1蛋白(PCOX-1 a)由COX-1基因制成,但在其mRNA中保留了内含子1。 PCOX-1蛋白还含有COX-1 mRNA外显子5-8的框内缺失。 COX-3和PCOX mRNA在犬的大脑皮层中表达,在其他组织中的表达量较少。在人类中,COX-3 mRNA的表达约为5.2kb,在大脑皮层和心脏中含量最高。内含子1在哺乳动物COX-1基因中的长度和序列均保守。该内含子包含一个ORF,该ORF会将30-34aa的氨基酸(取决于哺乳动物的种类)插入疏水信号肽中,该信号肽将COX-1引入内质网和核膜的内腔。 COX-3和PCOX-1a作为膜结合蛋白在昆虫细胞中有效表达。信号肽未从任何一种蛋白质上切下,并且两种蛋白质都被糖基化。 COX-3,而不是PCOX-1 a,具有糖基化依赖性的环氧合酶活性。犬COX-3活性与鼠COX-1和-2的比较表明,该酶被对乙酰氨基酚,非那西丁,安替比林和双嘧啶等镇痛/解热药选择性抑制,并被某些非甾体类抗炎药有效抑制。因此,抑制COX-3可能代表了这些药物减轻疼痛甚至发烧的主要中心机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号